217 - 228 of 7695 results
1.5 CME CREDITS

Human beings have understood the effects of chronic obstructive pulmonary disease (COPD) for centuries. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms and disease staging. In this discussion, Dr. Devarajan will review the staging of COPD and how staging ties into optimal treatments. We will also spend some time reviewing useful prognostic scores, lung cancer screening practices in 2021, and the approach to the breathless patient. Dr. Kumar will focus on the topic of essential basics of interstitial lung diseases for the community of physicians and other clinical healthcare professionals. This will include an overview of various types of interstitial lung diseases with brief discussion on clinical features and radiographic features that distinguish them from each other. This presentation will also highlight some of the newer therapies and advanced treatment options.


1 CME CREDIT

Alcohol use frequently co-occurs with anxiety disorders, especially during the highly anxiety-provoking circumstances of the current pandemic. People increasingly self-medicate their stress with alcohol, sometimes leading to frank alcohol use disorder. Despite alcohol’s legal status and social acceptability in many countries, it remains a potentially dangerous, toxic substance. Withdrawal from alcohol can be fatal, and medically managed withdrawal is often necessary to ensure patient safety. In this presentation, we will describe the fundamental pharmacology and acute presentations of alcohol use disorder and discuss counseling approaches. We will then explore the clinical aspects of the three FDA-approved medications for its treatment: disulfiram, naltrexone, and acamprosate. We will conclude with some novel ideas about future directions in the pharmacotherapy of alcohol use disorders.


1 CME CREDIT

Managing Obesity in Primary Care Practice

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

Obesity is the most prevalent chronic disease of the modern era in the U.S. and around the world, affecting both the adult and pediatric population. Although many believe that helping patients to achieve a healthy weight is of minimal complexity, weight regulation and management is a challenging endeavor. In this talk, the faculty will explore the complexities of obesity and offer a range of strategies (behavioral, therapeutic, and surgical) to help you in the quest to address overweight and obesity in your practice.


1 CME CREDIT

Understanding and Improving Vaccine Hesitancy in African American Patients

Episode 7: Bridging the Gap: Conversations with Dr. Hall

1.00 CME

This session will provide an overview of the health disparities related to the acceptance of vaccines among racial and ethnic groups in the US. We will discuss the historical basis for some of the apprehensions that exist in the African American community. We will look at conspiracy theories that are circulated regarding vaccines and discuss ways to reassure patients about the safety and any real risks. Finally, we will discuss best practices related to COVID-19 vaccine discussions with patients who are hesitant to accept.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the incidence and clinical features of vaccine-induced thrombotic thrombocytopenia (VITT) and the epidemiology and treatment of emerging COVID-19 variants.


woman examines her incontinence brief
1 CME CREDIT

Curb the Urge: Overactive Bladder for Primary Care

An Interactive Video Experience

1.00 CME/MOC
1.00 AANP | 0.33 Pharmacology

Experience this interactive video-based activity designed to increase your knowledge of the diagnosis and management of overactive bladder, a common condition that can have a devastating adverse effect on patients’ quality of life. Join expert faculty as they discuss OAB through a combination of video, quiz-questions, pop-up teaching points, and downloadable resources. Learn the latest guideline recommendations for OAB testing and treatment and review non-pharmacologic management options as well as the indications, safety, and efficacy of currently available medications. Through this activity, you will have access to a robust resource library, including slides, abstracts, and practice tools selected by the faculty, and which can be downloaded for future reference.


1 CME CREDIT

This talk will focus on the normal aging process in older adults. Specifically, the faculty will discuss hormonal changes, including changes in estrogen and testosterone levels. The faculty will also review physiologic changes and speak to how age impacts the circadian pattern of body temperature, cortisol levels, and sleep. Following this session, you will have a full picture of possible treatments—as well as their risks and benefits—for common symptoms associated with age-related hormonal changes.


1 CME CREDIT

Microaggressions are everyday occurrences that impact an individual’s sense of well-being. They occur because of implicit bias and can have an effect on our relationships with our patients, colleagues, and on our own sense of well-being. Repetitive exposure can also have an impact on the individual. The faculty will use examples to discuss the concept of microaggression, including definitions and terminology. From this talk, you will receive strategies for managing occurrences in the moment and frameworks for recognizing and reducing implicit bias.


0.75 CME CREDIT

This lecture will provide a comprehensive overview of contraceptive options for women of child-bearing ages. The significance and impact of prescribing practices on women will be discussed highlighting the importance of reproductive planning in all female patients with childbearing potential. Principles of effective contraceptive counseling will be outlined. Risks, benefits and medical indications for various contraceptive methods will be reviewed. Initiation and management of noncompliance with various contraceptive methods will also be discussed. A practical approach to management of contraceptive side effects will be discussed as well as risk/benefit assessments in choice of most appropriate contraceptive options.


0.5 CME CREDIT

Cardiovascular risk factors leading to the leading causes of death in the United States have their origins in the pediatric age group. This session is intended to give primary care providers a high level view of screening and management for cardio-metabolic risk factors in the pediatric age group based on the most up-to-date guidelines.


0.75 CME CREDIT

With the widespread accessibility to information on the Internet, much of which is not necessarily evidence-based, it appears that patients are more frequently consulting with their caregivers about vague somatic complaints that they think are due to exposure to various microbial organisms. Chronic Lyme disease has become a favorite disease due to some well-publicized celebrities announcing that they are suffering from this disorder. Patients also complain from the effects of mold exposure (“Toxic mold”), parasite infestations (delusions of parasitosis or Morgellon disease), among others. Patients can be very insistent, demanding therapies that are not supported by evidence. This presentation will assist practitioners as to how to appropriately diagnose and counsel patients about these various disorders.


0.75 CME CREDIT

In this session faculty will discuss pertinent updates for the primary care provider related to community acquired pneumonia (CAP). Dr. Ellie JC Goldstein will walk you through the bacteria which leads to CAP, in order to help understand how this disease evolves. He will describe the most up to date testing and treatment guidelines and explain who procalcitonin can play a role in the diagnosis and management of CAP. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/18/2020, and they are subject to change as new information is published.